Docking-based virtual screening of Schiff's bases of GABA: A prospective to novel GABA-AT inhibitors

Medicinal Chemistry Research

Volumn 21, Issue 10, 2012, Pages 3063-3072

  Bansal, S K ^a   Sinha, B N ^b   Khosa, R L ^a  

^a BHARAT INSTITUTE OF TECHNOLOGY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

AutoDock 4.0; GABA; GABA AT inhibitor; Lamarckian genetic algorithm; Ligand docking; Schiff's bases

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; 4 AMINOBUTYRIC ACID; SBG 110; SBG 164; SBG 195; SCHIFF BASE; UNCLASSIFIED DRUG; VIGABATRIN;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; COMPUTER MODEL; CRYSTAL STRUCTURE; DRUG INHIBITION; DRUG SCREENING; DRUG STRUCTURE; ENERGY; GENETIC ALGORITHM; MOLECULAR DOCKING; PROTEIN INTERACTION; VIRTUAL REALITY;

EID: 84866359901     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9843-6     Document Type: Article

References (31)

1. Abraham DJ (2003) Burger's medicinal chemistry and drug discovery, 6th edn. John Wiley & sons, New York
2. Allison SA, Bacquet RJ, McCammon JA (1998) Simulation of the diffusion-controlled reaction between superoxide and superoxide dismutase II: detailed models. Biopolymers 27:251-269
3. Bansal SK, Sinha BN, Khosa RL, Olson AJ (2010a) Novel GABAAT inhibitors: QSAR and docking based virtual screening of phenyl-substituted b-phenyl ethylidene hydrazine analogs. Med Chem Res 19:S114
4. Bansal SK, Sinha BN, Khosa RL, Olson AJ (2010b) Novel GABAAT inhibitors: QSAR and docking based virtual screening of phenyl-substituted b-phenyl ethylidene hydrazine analogs. Med Chem Res. doi:10.1007/s00044-010-9390-6
5. Bansal SK, Sinha BN, Khosa RL (2011) QSAR and docking-based computational chemistry approach to novel GABA-AT inhibitors: kNN-MFA based 3DQSAR model for phenyl-substituted analogs of b-phenylethylidene hydrazine. Med Chem Res 20: 549-553
6. Barril X, Morley SD (2005) Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. J Med Chem 48:4432-4443
7. Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron 36:3219-3228
8. Goodford PJ (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28:849-857
9. Goodsell DS, Olson AJ (1990) Automated docking of substrates to proteins by simulated annealing. Proteins Struct Funct Genet 8:195-202
10. Hawkins PCD, Skillman AG, Nicholls A (2007) Comparison of shape matching and docking as virtual screening tools. J Med Chem 50:74-82
11. Karlsson A, Fonnum F, Malthe-Sørenssen D, Storm-Mathisen J (1974) Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. J Biochem Pharmacol 23:3053-3061
12. Krogsgaard-Larsen P (1981) Gamma aminobutyric acid agonists, antagonists, and uptake inhibitors: design and therapeutic aspects. J Med Chem 24:1377-1383
13. Kuntz ID (1992) Structure-based strategies for drug design and discovery. Science 257:1078-1082
14. Kwon OS, Park J, Churchich JE (1992) Brain 4-aminobutyrate aminotransferase: isolation and sequence of a cDNA encoding the enzyme. J Biol Chem 267:7215-7216
15. Lill MA, Danielson ML (2011) Computer aided drug design platform using PyMOL. J Comput Aided Mol Des 25:13-19
16. Morris GM, Goodsell DS, Huey R, Olson AJ (1996) Distributed automated docking of flexible ligands to proteins: parallel applications of autodock 2.4. J Comput Aided Mol Des 10: 293-304
17. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem 19:1639-1662
18. Nogardy T, Weaver DF (2005) Medicinal Chemistry: a molecular and biochemical approach, 3rd edn. Oxford University Press, New York
19. Osolodkin DI, Chupakhin VI, Palyulin VA, Zefirov NS (2009) Molecular modeling of ligand-receptor interaction in GABAC receptor. J Mol Graphics Mod 27:813-821
20. Sharp K, Fine R, Honig B (1987) Computer simulations of the diffusion of a substrate to an active site of an enzyme. Science 236:460-1463
21. Silverman RB, Clift MD (2008) Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of GABA aminotransferase. Bioorg Med Chem Lett 18:3122-3125
22. Silverman RB, Durkee SC, Invergo BJ (1986) 4-Amino-2-(substituted methyl)-2-butenoic acids: substrates and potent inhibitors of gamma aminobutyric acid aminotransferase. J Med Chem 29: 764-770
23. Smith AJ, Simpson PB (2003) Methodological approaches for the study of GABAA receptor pharmacology and functional responses. Anal Bioanal Chem 377:843-851
24. Solis FJ, Wets RJ-B (1981) Minimization by random search techniques. Math Oper Res 6:19-30
25. Sowa B, Rauw G, Davood A, Fassihi A, Knaus EE, Baker GB (2005) Design and biological evaluation of phenyl substituted analogs of b-phenyl ethylidene hydrazine. Bioorg Med Chem 13:4389-4395
26. Storici P, Capitani G, Baise DD, Moser M, John RA, Jansonius JN, Schirmer T (1999) Crystal structure of GABA aminotransferase, a target for antiepileptic drug therapy. Biochemistry 38:8628-8634
27. Storici P, Baise DD, Bossa F, Bruno S, Mozzarelli A, Peneff C, Silverman RB, Schirmer T (2005) Structure of c-amino butyric acid (GABA) aminotransferase, a pyridoxal 50-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with c-ethynyl- GABA and with the antiepilepsy drug vigabatrin. J Biol Chem 279:363-373
28. Taylor RD, Jewsbury PJ, Essex JW (2002) A review of protein-small molecule docking methods. J Comput Aided Mol Des 16: 151-166
29. Toney MD, Pascarella S, Baise DD (1995) Active site model for c-amino butyrate aminotransferase explains substrate specificity and inhibitor reactivities. Protein Sci 4:2226-2374
30. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S, Weiner PA (1984) New force field for molecular mechanical simulation of nucleic acid and proteins. J Am Chem Soc 106:765-784
31. Young DC (2009) Computational drug design. John Wiley & Sons, New York